Bao-hui Liu

P.R. China
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

ACSL4 suppresses glioma cells proliferation via activating ferroptosis.

ACSL4 suppresses glioma cells proliferation via activating ferroptosis.

Journal: Oncology reports

Published: June 01, 2019

PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells.

PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells.

Journal: Oncology reports

Published: May 27, 2019

Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.

Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.

Journal: Disease markers

Published: June 17, 2018

PI3Kβ inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells.

PI3Kβ inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells.

Journal: Oncology reports

Published: May 31, 2018

RIP3 deficiency protects against traumatic brain injury (TBI) through suppressing oxidative stress, inflammation and apoptosis: Dependent on AMPK pathway.

RIP3 deficiency protects against traumatic brain injury (TBI) through suppressing oxidative stress, inflammation and apoptosis: Dependent on AMPK pathway.

Journal: Biochemical and biophysical research communications

Published: February 02, 2018

TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells.

TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells.

Journal: Oncology reports

Published: March 24, 2017

Puerarin inhibits proliferation and induces apoptosis in human glioblastoma cell lines.

Puerarin inhibits proliferation and induces apoptosis in human glioblastoma cell lines.

Journal: International journal of clinical and experimental medicine

Published: April 13, 2015

LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.

LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.

Journal: International journal of clinical and experimental pathology

Published: December 10, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026